Evidence map›Paper›PMID 33097936›Full record

Trial reportThe Journal of nutrition2021

Time Course and Sex Effects of α-Linolenic Acid-Rich and DHA-Rich Supplements on Human Plasma Oxylipins: A Randomized Double-Blind Crossover Trial.

Melissa Gabbs, Peter Zahradka, Carla G Taylor, Harold M Aukema

2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02317588 phase1completednot on this map

Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans

TypeinterventionalSponsorUniversity of ManitobaRan2014 to 2016Enrolled12ConditionsHealthyArmsFlax Oil, Fish Oil
NCT07237113 nacompletednot on this map

Effects of Omega-3 Fatty Acid Supplementation on Muscle Damage and Oxylipin Production Induced by Eccentric Exercise in Young Men

TypeinterventionalSponsorInstituto de Ciencias de la Salud, Universidad de O'HigginsRan2021 to 2024Enrolled30ConditionsDamage MuscleArmsPlacebo, Omega
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. The Emerging Parkinson's Disease Oxylipin-Ome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Plant extracts and omega-3 supplementation modulate hippocampal oxylipin profile in response to LPS-induced neuroinflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa GabbsDepartment of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Peter ZahradkaDepartment of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Carla G TaylorDepartment of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Harold M AukemaDepartment of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
University of Manitoba · CA

Funding

CIHR MOP133667CIHR RPA 132173
6 · The paper itself

Abstract

backgroundDifferences in health effects of dietary α-linolenic acid (ALA) and DHA are mediated at least in part by differences in their effects on oxylipins.

objectivesTime course and sex differences of plasma oxylipins in response to ALA- compared with DHA-rich supplements were examined.

methodsHealthy men and women, aged 19-34 y and BMI 18-28 kg/m2, were provided with capsules containing ∼4 g/d of ALA or DHA in a randomized double-blind crossover study with >6-wk wash-in and wash-out phases. Plasma PUFA and oxylipin (primary outcome) concentrations at days 0, 1, 3, 7, 14, and 28 of supplementation were analyzed by GC and HPLC-MS/MS, respectively. Sex differences, supplementation and time effects, and days to plateau were analyzed.

resultsALA supplementation doubled ALA concentrations, but had no effects on ALA oxylipins after 28 d, whereas DHA supplementation tripled both DHA and its oxylipins. Increases in DHA oxylipins were detected as early as day 1, and a plateau was reached by days 5-7 for 11 of 12 individual DHA oxylipins and for total DHA oxylipins. Nine individual DHA oxylipins reached a plateau in females with DHA supplementation, compared with only 4 in males. A similar time course and sex difference pattern occurred with EPA and its oxylipins with DHA supplementation. DHA compared with ALA supplementation also resulted in higher concentrations of 4 individual arachidonic acids, 1 linoleic acid, and 1 dihomo-γ-linolenic acid oxylipin, despite not increasing the concentrations of these fatty acids, further demonstrating that oxylipins do not always reflect their precursor PUFA.

conclusionsDHA compared with a similar dose of ALA has greater effects on both n-3 and n-6 oxylipins in young, healthy adults, with differences in response to DHA supplementation occurring earlier and being greater in females. These findings can help explain differences in dietary effects of ALA and DHA.This study was registered at clinicaltrials.gov as NCT02317588.

Indexed as

Dietary SupplementsAdultalpha-Linolenic AcidCross-Over StudiesDocosahexaenoic AcidsDouble-Blind MethodEicosapentaenoic AcidFemaleHumansMaleOxylipinsSex FactorsTime FactorsYoung Adultalpha-Linolenic AcidDocosahexaenoic AcidsEicosapentaenoic AcidOxylipinsDHAhumanoxylipinplasmasextime courseα-linolenic acid

Identifiers

PMID33097936
PMCPMC7948207
OpenAlexW3093724838

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.